Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [2092]

Androgen receptor signaling contributes to targeted therapy resistance in melanoma

Androgen receptor signaling contributes to targeted therapy resistance in melanoma

Tumour ‘signatures’ could provide key to more accurate treatment for deadliest cancers

Tumour ‘signatures’ could provide key to more accurate treatment for deadliest cancers

High-intensity focused ultrasound can control prostate cancer with fewer side effects

High-intensity focused ultrasound can control prostate cancer with fewer side effects

ecancer appoints two new world-renowned trustees, furthering the cause of quality, accessible cancer care across the world

ecancer appoints two new world-renowned trustees, furthering the cause of quality, accessible cancer care across...

New targeted radionuclide alpha therapy improves prostate cancer outcomes

New targeted radionuclide alpha therapy improves prostate cancer outcomes

ASCO 2022: Biomarker guidance allows patients 55 or older with low-grade luminal A-type breast cancer to avoid radiation therapy

ASCO 2022: Biomarker guidance allows patients 55 or older with low-grade luminal A-type breast cancer to avoid...

ASCO 2022: Immunotherapy before surgery associated with improved survival for soft-tissue sarcoma

ASCO 2022: Immunotherapy before surgery associated with improved survival for soft-tissue sarcoma

Patient voices a good predictor of cancer treatment outcomes

Patient voices a good predictor of cancer treatment outcomes

Study identifies causes of cancer

Study identifies causes of cancer

NICE reverses recommendation allowing use of novel urothelial carcinoma immunotherapy on the NHS

NICE reverses recommendation allowing use of novel urothelial carcinoma immunotherapy on the NHS

More from ecancer